Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNFα levels during treatment
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
1975 • 3,051 citations
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 • 2,565 citations
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
1997 • 1,651 citations
Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors
1986 • 1,433 citations
Etanercept Therapy in Rheumatoid Arthritis
1999 • 1,407 citations
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
2001 • 1,237 citations
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
1996 • 1,217 citations
An interleukin 1 like factor stimulates bone resorption in vitro
1983 • 1,017 citations
A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral Proteins
1990 • 977 citations
Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
1990 • 918 citations
Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
1993 • 837 citations
Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome
1995 • 805 citations
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
1998 • 761 citations
Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
1984 • 667 citations
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
2001 • 553 citations
Safety and Efficacy of a Soluble P75 Tumor Necrosis Factor Receptor (Enbrel, Etanercept) in Patients With Advanced Heart Failure
1999 • 397 citations
Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure
2001 • 386 citations
[Etanercept for therapy of rheumatoid arthritis].
2005 • 344 citations
Etanercept combined with conventional treatment in Wegener's granulomatosis: A six-month open-label trial to evaluate safety
2001 • 220 citations
Production of cytokines by bone marrow cells obtained from patients with multiple myeloma
1989 • 156 citations
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group
1995 • 153 citations
Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.
1999 • 100 citations
Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor
1996 • 85 citations
Etanercept in rheumatoid arthritis
2001 • 82 citations
TNF and IL‐6 are potent growth factors for OH‐2, a novel human myeloma cell line
1994 • 80 citations
Etanercept (Enbrel): update on therapeutic use
2000 • 72 citations
Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
1996 • 47 citations
Etanercept and urticaria in patients with juvenile idiopathic arthritis.
2000 • 46 citations
EVALUATION OF RECOMBINANT HUMAN SOLUBLE DIMERIC TUMOR NECROSIS FACTOR RECEPTOR FOR PREVENTION OF OKT3-ASSOCIATED ACUTE CLINICAL SYNDROME1,2
1996 • 45 citations
Autocrine Growth by Two Cytokines, Interleukin-6 and Tumor Necrosis Factor Alpha, in the Myeloma Cell Line KHM-1A
1990 • 31 citations
THE ROLE OF THE TWO TNF RECEPTORS IN PROLIFERATION, NF-κB ACTIVATION AND DISCRIMINATION BETWEEN TNF AND LTαSIGNALLING IN THE HUMAN MYELOMA CELL LINE OH-2
1996 • 27 citations
New insights in the clinical biology of multiple myeloma.
1997 • 17 citations
Multiple myeloma and other differentiated B-cell disorders.
1994 • 6 citations
Refractory multiple myeloma: recent advances in therapy.
1995 • 5 citations